Burning Rock Biotech Ltd (BNR): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-33.69M CNY
Year ended 2025-12-31
2018-12-31: -171.97M CNY2019-12-31: -271.01M CNY2020-12-31: -133.83M CNY2021-12-31: -682.22M CNY2022-12-31: -518.84M CNY2023-12-31: -263.89M CNY2024-12-31: -97.68M CNY2025-12-31: -33.69M CNY-33.69M CNY
2018-12-31 Free Cash Flow (CNY) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-33.69M CNYn/m2026-04-28, From 2025-01-01
2024-12-31-97.68M CNYn/m2026-04-28, From 2024-01-01
2023-12-31-263.89M CNYn/m2026-04-28, From 2023-01-01
2022-12-31-518.84M CNYn/m2025-04-29, From 2022-01-01
2021-12-31-682.22M CNYn/m2024-04-29, From 2021-01-01
2020-12-31-133.83M CNYn/m2023-04-20, From 2020-01-01
2019-12-31-271.01M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-171.97M CNYn/a2021-03-23, From 2018-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31-33.69M CNYn/m
Concord Medical Services Holdings Ltd (CCM)2025-12-31-258.15M CNYn/m

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗